Early vulvar lichen sclerosus: A histopathological challenge

Histopathology

Volumn 47, Issue 4, 2005, Pages 340-347

  Regauer, Sigrid ^a   Liegl, B ^a   Reich, O ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Diagnosis; Review; Vulvar dermatoses; Vulvitis

Indexed keywords

ACANTHOSIS; BASEMENT MEMBRANE; BIOPSY TECHNIQUE; DERMIS; EPIDERMIS; EXOCYTOSIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; LICHEN SCLEROSUS ET ATROPHICUS; LICHENOID; LYMPHOCYTIC INFILTRATION; MORBIDITY; PRIORITY JOURNAL; REMISSION; REVIEW; RISK FACTOR; SCAR FORMATION; SQUAMOUS CELL CARCINOMA; VULVA CARCINOMA;

ADULT; FEMALE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; MIDDLE AGED; TIME FACTORS; VULVAR DISEASES;

EID: 26444465550     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02209.x     Document Type: Review

References (29)

1. Weir RJ. Ichtyosis of the tongue and vulva. NY Med. J. 1875; 21; 240.
2. Berkely CP, Bonney V. Leukoplakic vulvitis and its relation to kraurosis vulvae and carcinoma vulvae. Br. J. Med. 1909; 2; 1739.
3. Breisky D. Über Kraurosis vulvae. Z. Heilkd. 1885; 6; 69-80.
4. Johnston JC, Sherwell S. White spot disease. J. Cut. Dis. 1902; 21; 302-307.
5. Montgomery FH, Ormsby OS. White spot disease (morphea guttata) and lichen sclerosus et atrophicus. J. Cutan. Dis. 1907; 25; 1-16.
6. Jeffcoate TNA. Chronic vulval dystrophies. Am. J. Obstet. Gynecol. 1966; 95; 61-74.
7. Ambros RA, Malfetano JH, Carlson JA et al. Non-neoplastic epithelial alterations of the vulva: recognition assessment and comparison of terminologies used among the various specialties. Mod. Pathol. 1997; 10; 401-408.
8. Carlson JA, Lamb P, Malfetano J et al. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod. Pathol. 1998; 11; 844-854.
9. Fung MA, LeBoit P. Light microscopic criteria for the diagnosis of early vulvar lichen sclerosus. A comparison with lichen planus. Am. J. Surg. Pathol. 1998; 22; 473-478.
10. Lukowsky A, Muche JM, Sterry W et al. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays. J. Invest. Oermatol. 2000; 115; 254-259.
11. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353; 1777-1783.
12. Regauer S, Reich O, Beham-Schmid C. Monoclonal gamma T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas. Am. J. Pathol 2002; 160; 1035-1045.
13. Azurdia RM, Luzzi GA, Byren I et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br. J. Dermatol. 1999; 140; 79-83.
14. Friedrich EG, MacLaren NK. Genetic aspects of vulvar lichen sclerosus. Am. J. Obstet. Gynecol. 1984; 150; 161-166.
15. Goolamali SK, Barnes EW, Irvine WJ et al. Organ specific antibodies in patients with lichen sclerosus. BMJ 1974; 4; 78-79.
16. Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus. Br. J. Dermatol. 1981; 104; 563-566.
17. Meyrick Thomas RH, Ridley CM, Black MM. The association of lichen sclerosus et atrophicus and autoimmune-related disease in males. Br. J. Dermatol. 1983; 109; 661-664.
18. Meyrick Thomas RH, Ridley CM, Black MM. Lichen sclerosus et atrophicus associated with systemic lupus erythematosus. J. Am. Acad. Dermatol. 1985; 13; 832-833.
19. Meyrick Thomas RH, Ridley CM, McGibbon DH et al. Lichen sclerosus et atrophicus and autoimmunity-a study of 350 women. Br. J. Dermatol. 1988; 118; 41-46.
20. Oyama N, Chan I, Neill SM et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362; 118-123.
21. Regauer S, Schwaiger P, Liegl B et al. Fetal microchimerism is common in normal and diseased vulvar skin. J. Invest. Dermatol. 2004; 122; 1059-1060.
22. Regauer S, Beham-Schmid C. Monoclonally rearranged gamma T-cell receptor in lichen sclerosus-a finding of clinical significance? Am. J. Dermatopathol. 2004; 26; 349-350; reply to Drs Kerl and Cerroni 351.
23. Regauer S. Immune dysregulation in lichen sclerosus. Eur. J. Cell Biol. 2005; 84; 273-277.
24. Carli P, Cattaneo A, Magnis AD et al. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur. J. Cancer Prev. 1995; 4; 491-495.
25. Scurry J, Flowers L, Wistuba I et al. Human papillomavirus, lichen sclerosis and vulvar squamous cell carcinoma. Int. J. Gynecol. Cancer 1998; 8; 298-306.
26. Scurry JP, Vanin K. Vulvar squamous cell carcinoma and lichen sclerosus. Australas. J. Dermatol. 1997; 38 (Suppl. 1); S20-25.
27. Cooper S, Gao XH, Powell JJ. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch. Dermatol. 2004; 140; 702-706.
28. Renaud-Vilmer C, Cavelier-Balloy B, Porcher R. et al. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch. Dermatol. 2004; 140; 709-712.
29. Neil S, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br. J. Dermatol. 2002; 147; 640-649.